EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 8 filers reported holding EVAXION BIOTECH A S in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $68 | -99.9% | 37,500 | +29.3% | 0.11% | +10.3% |
| Q3 2022 | $76,000 | -68.1% | 29,000 | -76.2% | 0.10% | -65.6% |
| Q2 2022 | $238,000 | -53.8% | 122,000 | -27.7% | 0.28% | -65.3% |
| Q1 2022 | $515,000 | -30.4% | 168,737 | +0.7% | 0.81% | -14.7% |
| Q4 2021 | $740,000 | +150.0% | 167,500 | +444.8% | 0.95% | +138.8% |
| Q3 2021 | $296,000 | -6.0% | 30,743 | -26.3% | 0.40% | -7.9% |
| Q2 2021 | $315,000 | -27.8% | 41,729 | -43.5% | 0.43% | -12.2% |
| Q1 2021 | $436,000 | – | 73,850 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 167,500 | $740,000 | 0.95% |
| LUMINUS MANAGEMENT LLC | 777,990 | $3,439,000 | 0.81% |
| Kepos Capital LP | 40,000 | $177,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 7,000 | $31,000 | 0.00% |
| MORGAN STANLEY | 3,696 | $16,000 | 0.00% |
| Citadel Advisors | 140,600 | $621,000 | 0.00% |
| Citadel Advisors | 13,900 | $61,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 25,600 | $114,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 30,180 | $134,000 | 0.00% |
| SIMPLEX TRADING, LLC | 400 | $1,000 | 0.00% |